Equity Overview
Price & Market Data
Price: $2.53
Daily Change: +$0.09 / 3.56%
Range: $2.31 - $2.53
Market Cap: $21,809,004
Volume: 9,598
Performance Metrics
1 Week: 12.17%
1 Month: 4.12%
3 Months: -5.60%
6 Months: -13.36%
1 Year: -5.24%
YTD: -15.10%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is in Phase 2 clinical studies for the treatment of solid tumor, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, colon cancer and glioblastoma multiforme, in combination with a range of anti-cancer regimens. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.